Literature DB >> 1915402

In vitro activity of cefpodoxime against staphylococci in comparison to other cephalosporins.

F Schumacher-Perdreau1, B Jansen, G Peters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915402     DOI: 10.1007/bf01967279

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

2.  In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Authors:  Y Utsui; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

3.  In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

5.  Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.

Authors:  C C Knapp; J Sierra-Madero; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  Studies on orally active cephalosporin esters.

Authors:  K Fujimoto; S Ishihara; H Yanagisawa; J Ide; E Nakayama; H Nakao; S Sugawara; M Iwata
Journal:  J Antibiot (Tokyo)       Date:  1987-03       Impact factor: 2.649

  6 in total
  1 in total

Review 1.  Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  J E Frampton; R N Brogden; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.